Literature DB >> 9438483

Natural history of Hymenoptera venom sensitivity in adults.

D B Golden1, D G Marsh, L R Freidhoff, K A Kwiterovich, B Addison, A Kagey-Sobotka, L M Lichtenstein.   

Abstract

BACKGROUND: Epidemiologic studies of Hymenoptera venom allergy in adults show a prevalence of positive venom skin test results, RASTs of 15% to 25%, or both, but most such individuals have had no systemic reactions to stings. The clinical significance and natural history of this apparently common sensitivity is uncertain.
OBJECTIVE: We sought to determine the natural history of venom sensitization by observing the rate of decrease or increase in sensitivity in normal adults over 5 to 10 years. The clinical significance of these findings is related to the frequency of systemic reactions to stings during the period of observation.
METHODS: Serial observations were planned in 520 volunteers and randomly selected subjects. Two follow-up visits were attempted, once after 2 to 3 years and again after 5 to 9 years, to perform repeat venom skin tests and RASTs and to review any history of interim stings and their outcomes.
RESULTS: Follow-up visits were conducted with 398 subjects (375 early visits and 205 late visits). Overall, in the 398 subjects with one or more visits after a mean of 4 years, skin test responses changed from positive to negative in 44 of 98 (45%) and from negative to positive in 27 of 309 (8.7%) of the subjects. Skin test responses changed from positive to negative in 29 of 87 (33%) subjects after 2.5 years and in 43 of 54 (80%) after 6.8 years. Even when the skin test response became negative, venom-specific IgE remained positive in 11 of 29 (38%) subjects after 2.5 years and in 13 of 43 (30%) after 6.8 years. The rate of loss of sensitivity was 12% per year, similar to retrospective estimates. Skin test sensitivity to venoms disappears more rapidly in these subjects without symptoms (half-life, 4 years) than in patients receiving venom immunotherapy (half-life, 7 years). Skin test responses changed from negative to positive in 23 of 288 (8%) subjects after 2.5 years and in 9 of 151 (6%) after 6.8 years. Insect stings caused no reaction in 120 subjects with a negative skin test response, but 17% (11 of 65) of subjects with a positive skin test response (but with a negative history) had systemic reactions when stung. There was no difference between the early and late visits in the frequency of systemic reactions reported. The risk may be higher than 17% for the specific individuals (67% after 2.5 years and 20% after 6.8 years) whose positive skin test responses persist for years. This risk is lower than that of patients with a positive history (50%) but higher than that of "normal" adults or venom-treated patients (<2%). It is still not clear whether any subset of adults with a positive skin test response but a negative history can be identified, in whom the risk of systemic sting reaction would justify venom immunotherapy even before any reaction occurs.
CONCLUSION: Asymptomatic venom sensitization in adults is common but transient, disappearing at the rate of 12% per year. However, the risk of a systemic reaction to a subsequent sting is significant in adults without symptoms but with positive venom skin test responses (17%) and may be higher when skin test sensitivity does persist for years.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438483     DOI: 10.1016/s0091-6749(97)70270-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

1.  Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.

Authors:  Susan A Rudders; Aleena Banerji; Daniel P Katzman; Sunday Clark; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2010-07       Impact factor: 6.347

2.  Risk of squamous cell carcinoma of the skin in relation to IgE: a nested case-control study.

Authors:  Joseph L Wiemels; John K Wiencke; Zhongze Li; Christian Ramos; Heather H Nelson; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-23       Impact factor: 4.254

Review 3.  Venom immunotherapy: an updated review.

Authors:  Darío Antolín-Amérigo; Carmen Moreno Aguilar; Arantza Vega; Melchor Alvarez-Mon
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

4.  Intracutaneous Skin Tests and Serum IgE Levels Cannot Predict the Grade of Anaphylaxis in Patients with Insect Venom Allergies.

Authors:  Moritz M Hollstein; Silke S Matzke; Lisa Lorbeer; Susann Forkel; Thomas Fuchs; Christiane Lex; Timo Buhl
Journal:  J Asthma Allergy       Date:  2022-07-07

Review 5.  Insect sting anaphylaxis.

Authors:  David B K Golden
Journal:  Immunol Allergy Clin North Am       Date:  2007-05       Impact factor: 3.479

6.  Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.

Authors:  Birgit Winkler; Caroline Bolwig; Ulla Seppälä; Michael D Spangfort; Christof Ebner; Ursula Wiedermann
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

7.  Immunogenicity of Milk Protein-Containing Hydrophilic Gel Patch for Epicutaneous Immunotherapy for Milk Allergy.

Authors:  Sayami Ito; Sachiko Hirobe; Yu Kuwabara; Mizuho Nagao; Mio Saito; Ying-Shu Quan; Fumio Kamiyama; Takao Fujisawa; Naoki Okada
Journal:  Pharm Res       Date:  2020-01-16       Impact factor: 4.200

8.  Bee- and Wasp-Venom Sensitization in Schoolchildren of High- and Low-Socioeconomic Status Living in an Urban Area of Indonesia.

Authors:  Aldian I Amaruddin; Jan Pieter R Koopman; Munawir Muhammad; Serge A Versteeg; Sitti Wahyuni; Ronald van Ree; Maria Yazdanbakhsh; Firdaus Hamid; Erliyani Sartono
Journal:  Int Arch Allergy Immunol       Date:  2021-05-05       Impact factor: 2.749

9.  Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol.

Authors:  Vincenzo Patella; Giovanni Florio; Ada Giuliano; Carmine Oricchio; Giuseppe Spadaro; Gianni Marone; Arturo Genovese
Journal:  J Allergy (Cairo)       Date:  2012-05-24

10.  In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure.

Authors:  Flurina Meiler; Judith Zumkehr; Sven Klunker; Beate Rückert; Cezmi A Akdis; Mübeccel Akdis
Journal:  J Exp Med       Date:  2008-11-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.